- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01755026
Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery
June 12, 2013 updated by: Michael Stitely
Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery Receiving Two Differing Doses of Pre-operative Cefazolin.
Patients undergoing Cesarean delivery (C-Section) with a body mass index of 35 or greater (this BMI number is in the obese range) will be given either 2 grams or 4 grams of an antibiotic before surgery.
The antibiotic is intended to prevent infection from the surgery.It is unknown what the best dose for large women is for the usual medicine used for this purpose (an antibiotic medicine called cefazolin).Samples of the tissue just under the skin will be biopsied at the time the incision is made and at the time the cut is stitched or stapled closed.
A sample of the muscle of the womb will be taken as the womb is stitched closed after the delivery.
Blood tests will be done at the start and end of surgery to test the antibiotic level.
A blood sample will be taken from the umbilical cord after the baby has been delivered and the umbilical cord has been cut.
The umbilical cord blood sample will be tested for the antibiotic level.These tests will be used to find out if the usual dose of medicine is enough or if more medicine is needed to prevent infection in large women undergoing c-sections.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26506
- West Virginia University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Age 18 years or above
- Body mass index (BMI) of 35 or greater at the time of the first obstetric clinic visit
- Undergoing cesarean delivery
Exclusion Criteria:
- BMI less than 35.
- Not undergoing Cesarean delivery.
- Age less than 18 years.
- Pre-existing infection.
- Allergy to cephalosporin medications or a history of an anaphylactic reaction to penicillin.
- Cesarean delivery being performed under emergent circumstances.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 2 gram dose of cefazolin
2 gram dose of pre-operative cefazolin
|
2 gram dose for pre-operative prophylaxis
Other Names:
4 gram dose for pre-operative prophylaxis
Other Names:
|
Experimental: 4 gram Dose
4 gram dose of pre-operative prophylaxis
|
2 gram dose for pre-operative prophylaxis
Other Names:
4 gram dose for pre-operative prophylaxis
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cefazolin Levels
Time Frame: 2 hours
|
Cefazolin levels
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: William H Holls, MD, West Virginia University
- Study Chair: Michael L Stitely, MD, West Virginia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2010
Primary Completion (Actual)
July 1, 2011
Study Completion (Actual)
November 1, 2012
Study Registration Dates
First Submitted
June 29, 2011
First Submitted That Met QC Criteria
December 18, 2012
First Posted (Estimate)
December 21, 2012
Study Record Updates
Last Update Posted (Estimate)
August 21, 2013
Last Update Submitted That Met QC Criteria
June 12, 2013
Last Verified
June 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-22512
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on cefazolin
-
Abdul El-RabbanyNot yet recruitingOrthognathic Surgical Site Infection
-
B. Braun Medical Inc.ParexelCompleted
-
B. Braun Medical Inc.Terminated
-
University of Missouri-ColumbiaCompletedWounds and Injuries | Fractures, ClosedUnited States
-
Aultman Health FoundationCompletedWound InfectionUnited States
-
Stanford UniversityCompletedPre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery PatientsAortic Valve Disorder | Congenital Heart DiseasesUnited States
-
Phillip Brian SmithEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSepsis | PrematurityBrazil
-
Brigham and Women's HospitalCompletedAntibiotic ProphylaxisUnited States
-
Chang Gung Memorial HospitalNot yet recruitingPeriprosthetic Joint InfectionTaiwan